dc.contributor.author | Cañada-García, Javier E. | es_ES |
dc.contributor.author | Moure, Zaira | es_ES |
dc.contributor.author | Sola-Campoy, Pedro J. | es_ES |
dc.contributor.author | Delgado-Valverde, Mercedes | es_ES |
dc.contributor.author | Cano García, María Eliezer | es_ES |
dc.contributor.author | Gijón, Desirèe | es_ES |
dc.contributor.author | González, Mónica | es_ES |
dc.contributor.author | Gracia-Ahufinger, Irene | es_ES |
dc.contributor.author | Larrosa, Nieves | es_ES |
dc.contributor.author | Mulet, Xavier | es_ES |
dc.contributor.author | Pitart, Cristina | es_ES |
dc.contributor.author | Rivera, Alba | es_ES |
dc.contributor.author | Bou, Germán | es_ES |
dc.contributor.author | Calvo, Jorge | es_ES |
dc.contributor.author | Cantón, Rafael | es_ES |
dc.contributor.author | González-López, Juan José | es_ES |
dc.contributor.author | Martínez-Martínez, Luis | es_ES |
dc.contributor.author | Navarro, Ferrán | es_ES |
dc.contributor.author | Oliver, Antonio | es_ES |
dc.contributor.author | Palacios-Baena, Zaira R. | es_ES |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2022-12-02T14:53:51Z | |
dc.date.available | 2022-12-02T14:53:51Z | |
dc.date.issued | 2022-06-30 | es_ES |
dc.identifier.issn | 1664-302X | es_ES |
dc.identifier.uri | https://hdl.handle.net/10902/26803 | |
dc.description.abstract | Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain.
Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis.
Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were bla OXA-48 (263/377), bla KPC-3 (62/377), bla VIM-1 (28/377), and bla NDM-1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5).
Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3. | es_ES |
dc.description.sponsorship | Funding: This research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I + D + i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014– 2020. CIBER – Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU also supported this work.
Acknowledgments: We thank all participating hospitals and the Genomics Unit of the Centro Nacional de Microbiología for support with DNA sequencing. | es_ES |
dc.format.extent | 13 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Frontiers Research Foundation | es_ES |
dc.rights | Attribution 4.0 International | * |
dc.rights | © 2022 The authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | Frontiers in microbiology June 2022 Volume 13 Article 918362 | es_ES |
dc.title | CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumonia e and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3 | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | https://doi.org/10.3389/fmicb.2022.918362 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.3389/fmicb.2022.918362 | es_ES |
dc.type.version | publishedVersion | es_ES |
dc.description.other | CARB-ES-19 study | es_ES |
dc.description.other | Klebsiella pneumoniae | es_ES |
dc.description.other | Carbapenemases | es_ES |
dc.description.other | High-risk clones | es_ES |
dc.description.other | Whole genome sequencing | es_ES |